EUVIMEDEUVIMED entdecken
Crossref

Transcriptomic classification and clinicopathologic correlation of hepatocellular neoplasms with steatotic features in non-cirrhotic livers

Lee-Ching Zhu, Sushant A Patil, Peyton C Kuhlers, Andrew M Moon, Jesse R Raab, Adam D Pfefferle, Michele C Hayward, Albert Wielgus, Gabriela E De la Cruz, Surekha Bantumilli, Katherine A Hoadley, Jason D Merker

Pathology · 2026-06 · 58 (4) · 399-410

DOI: 10.1016/j.pathol.2025.12.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology, 2026-06. Verfasst von Lee-Ching Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer C…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Adenoma, Liver Cell, Fatty Liver. Die Arbeit nennt 75 Literaturangaben. Gefördert von: NCI NIH HHS, Illumina, The University of North Carolina at Chapel Hill Department of Pathology and Laboratory Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Differentiating early-stage hepatocellular carcinoma (HCC) from hepatocellular adenoma (HCA), particularly in the context of steatosis, remains a diagnostic challenge. Accurate distinction is essential for appropriate clinical management, yet reliable ancillary assays are limited. This study focuses on hepatocellular neoplasms with steatotic change in non-cirrhotic livers, aiming to minimise confounding factors from cirrhosis and to identify genetic alterations specific to tumour biology. Using total RNA sequencing, we analysed the gene expression profiles of 12 HCA cases, ten HCC cases (including eight with steatotic change) and seven paired non-neoplastic liver samples. Transcriptomic profiles were subsequently correlated with histopathologic features and clinical outcomes. Unsupervised clustering segregated HCC from HCA and non-neoplastic liver, indicating distinct transcriptional signatures. Three histologically ambiguous hepatocellular neoplasms were also evaluated, and their clustering patterns aligned with their long-term clinical behaviour, suggesting the potential clinical utility of transcriptomic classification in diagnostically uncertain cases. Differential expression analysis identified both protein-coding and non-coding genes that may serve as candidate biomarkers for future RNA-based or immunohistochemical assays. Pathway analysis revealed distinct oncogenic and metabolic signalling cascades differentiating HCC from HCA. These findings demonstrate that transcriptomic profiling offers a promising molecular approach to distinguishing HCC from HCA and assists in the classification of indeterminate hepatocellular neoplasms. With further validation, these molecular signatures and their surrogate biomarkers have the potential to enhance diagnostic accuracy, refine histologic criteria, guide clinical management and improve our understanding of hepatocarcinogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularAdenoma, Liver CellFatty LiverHumansFemaleTranscriptomeGene Expression ProfilingMaleMiddle AgedAgedBiomarkers, TumorDiagnosis, DifferentialLiver

Stichwörter der Autor:innen

CPLX2CST1gene expression profilinghepatocellular adenomahepatocellular carcinomahepatocellular neoplasmmetabolic-dysfunction-associated steatotic liver disease

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, U…
  • Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Genetics, School of Medicine, University of North Carolina at Chapel, Chapel Hill, NC, USA.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill…
  • Translational Genomics Laboratory at Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Pathology Services Core at Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.

Förderung

  • NCI NIH HHS
  • Illumina
  • The University of North Carolina at Chapel Hill Department of Pathology and Laboratory Medicine

Zitieren

APA

Zhu, L. C., Patil, S. A., Kuhlers, P. C., Moon, A. M., Raab, J. R., Pfefferle, A. D., Hayward, M. C., Wielgus, A., De la Cruz, G. E., Bantumilli, S., Hoadley, K. A., & Merker, J. D. (2026). Transcriptomic classification and clinicopathologic correlation of hepatocellular neoplasms with steatotic features in non-cirrhotic livers. Pathology, 58(4), 399-410. https://doi.org/10.1016/j.pathol.2025.12.006

Vancouver

Zhu LC, Patil SA, Kuhlers PC, Moon AM, Raab JR, Pfefferle AD, et al. Transcriptomic classification and clinicopathologic correlation of hepatocellular neoplasms with steatotic features in non-cirrhotic livers. Pathology. 2026;58(4):399-410. doi:10.1016/j.pathol.2025.12.006

BibTeX
@article{Zhu2026,
  author = {Zhu, Lee-Ching and Patil, Sushant A and Kuhlers, Peyton C and Moon, Andrew M and Raab, Jesse R and Pfefferle, Adam D and Hayward, Michele C and Wielgus, Albert and De la Cruz, Gabriela E and Bantumilli, Surekha and Hoadley, Katherine A and Merker, Jason D},
  title = {Transcriptomic classification and clinicopathologic correlation of hepatocellular neoplasms with steatotic features in non-cirrhotic livers},
  journal = {Pathology},
  year = {2026},
  volume = {58},
  number = {4},
  pages = {399--410},
  doi = {10.1016/j.pathol.2025.12.006}
}
Kostenlos starten →